[go: up one dir, main page]

MX356551B - Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. - Google Patents

Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.

Info

Publication number
MX356551B
MX356551B MX2012009806A MX2012009806A MX356551B MX 356551 B MX356551 B MX 356551B MX 2012009806 A MX2012009806 A MX 2012009806A MX 2012009806 A MX2012009806 A MX 2012009806A MX 356551 B MX356551 B MX 356551B
Authority
MX
Mexico
Prior art keywords
preventing
exfoliating
antiseborrheic
antiseptic
acne
Prior art date
Application number
MX2012009806A
Other languages
English (en)
Other versions
MX2012009806A (es
Inventor
Vázquez Cervantes Laura
Agustín Rogelio Magaña Castro José
Peña Santoyo Pedro
Original Assignee
Grupo Medifarma S A De C V Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grupo Medifarma S A De C V Star filed Critical Grupo Medifarma S A De C V Star
Priority to MX2012009806A priority Critical patent/MX356551B/es
Priority to TW102129966A priority patent/TW201416071A/zh
Priority to UY0001034985A priority patent/UY34985A/es
Priority to US14/421,616 priority patent/US20150231098A1/en
Priority to CA2882392A priority patent/CA2882392C/en
Priority to ARP130102975A priority patent/AR092199A1/es
Priority to PCT/MX2013/000099 priority patent/WO2014030992A2/es
Publication of MX2012009806A publication Critical patent/MX2012009806A/es
Publication of MX356551B publication Critical patent/MX356551B/es
Priority to US16/008,210 priority patent/US20180353448A1/en
Priority to US16/371,670 priority patent/US10792258B2/en
Priority to US17/063,458 priority patent/US20210093593A1/en
Priority to US17/855,072 priority patent/US12083085B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relaciona con una composición hidrosoluble antimicrobiana, exfoliante y seborreguladora que comprende una combinación de Dialil Óxido de Disulfuro Modificado (ODD-M) y ácido alfa hidroxietanóico (ácido glicólico) que actúa eliminando las bacterias que afectan la piel incluyendo aquellas causantes del acné, dicha composición también proporciona una limpieza profunda, una acción exfoliante, disminuye la cohesión epidérmica que facilita el recambio celular, previniendo la ocurrencia de diversas formas de acné en la piel y adicionalmente produce efectos seborreguladores al evitar el taponamiento de las glándulas sebáceas.
MX2012009806A 2012-08-23 2012-08-23 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. MX356551B (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
MX2012009806A MX356551B (es) 2012-08-23 2012-08-23 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
TW102129966A TW201416071A (zh) 2012-08-23 2013-08-20 具抗菌、調節皮脂分泌及去角質功效之組成物以去除或防治粉刺
UY0001034985A UY34985A (es) 2012-08-23 2013-08-21 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
ARP130102975A AR092199A1 (es) 2012-08-23 2013-08-22 Composicion antiseptica, antiseborreica y exfoliante para eliminar o prevenir el acne
CA2882392A CA2882392C (en) 2012-08-23 2013-08-22 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US14/421,616 US20150231098A1 (en) 2012-08-23 2013-08-22 Antiseptic, antiseborrheic, exfoliating composition for getting rid of or preventing acne
PCT/MX2013/000099 WO2014030992A2 (es) 2012-08-23 2013-08-22 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné
US16/008,210 US20180353448A1 (en) 2012-08-23 2018-06-14 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US16/371,670 US10792258B2 (en) 2012-08-23 2019-04-01 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US17/063,458 US20210093593A1 (en) 2012-08-23 2020-10-05 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US17/855,072 US12083085B2 (en) 2012-08-23 2022-06-30 Antiseptic, antiseborrheic, exfoliating composition to remove or prevent acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012009806A MX356551B (es) 2012-08-23 2012-08-23 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.

Publications (2)

Publication Number Publication Date
MX2012009806A MX2012009806A (es) 2014-02-24
MX356551B true MX356551B (es) 2018-06-04

Family

ID=49230828

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012009806A MX356551B (es) 2012-08-23 2012-08-23 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.

Country Status (7)

Country Link
US (5) US20150231098A1 (es)
AR (1) AR092199A1 (es)
CA (1) CA2882392C (es)
MX (1) MX356551B (es)
TW (1) TW201416071A (es)
UY (1) UY34985A (es)
WO (1) WO2014030992A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
CN111763630A (zh) * 2019-03-27 2020-10-13 深圳微健康基因科技有限公司 表皮葡萄球菌及其用途
EP4146158A1 (en) * 2020-05-06 2023-03-15 Mary Kay, Inc. Cosmetic composition comprising gluconolactone and glycolic acid

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
SE430609B (sv) 1976-12-21 1983-11-28 Sca Development Ab Sett att ur cellulosaderivat framstella absorberande material
US4376118A (en) 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
US5310562A (en) 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
US5009895A (en) 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
JPH08510251A (ja) 1993-05-07 1996-10-29 ビー マーゴリン、ソロモン 線維症の病変の修復と予防のための組成物および方法
JP3416145B2 (ja) 1995-12-21 2003-06-16 ファイザー インク． 注射用キノロン製剤
US5958420A (en) 1997-03-13 1999-09-28 Nortrade Medical, Inc. Treatment of burns, cuts, and abrasions of the skin
US6365131B1 (en) 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
ES2221365T3 (es) 1998-03-17 2004-12-16 Solomon B. Margolin Composiciones y metodos topicos antisepticos.
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
AU1226099A (en) 1998-09-18 2000-04-10 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
US20020028784A1 (en) 2000-03-10 2002-03-07 Nest Gary Van Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
IN191090B (es) 2000-08-29 2003-09-20 Ranbanx Lab Ltd
JP4077320B2 (ja) 2001-01-29 2008-04-16 塩野義製薬株式会社 ５−メチル−１−フェニル−２−（１ｈ）−ピリドンを有効成分として含有する医薬製剤
US20030103941A1 (en) 2001-10-09 2003-06-05 Crombleholme Timothy M. Materials and methods for preventing or reducing scar formation
CH696420A5 (de) 2002-09-13 2007-06-15 Mepha Ag Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung.
TW200501952A (en) 2003-02-21 2005-01-16 Shionogi & Co Pirfenidone gel formulations
EP1596883A1 (en) 2003-02-28 2005-11-23 Intermune, Inc. Interferon drug therapy for the treatment of viral diseases and liver fibrosis
AU2003225670A1 (en) 2003-02-28 2004-09-28 Intermune, Inc. Interferon drug therapy for the treatment of viral diseases and liver fibrosis
US20060198823A1 (en) 2003-04-04 2006-09-07 Blatt Lawrence M Compositions and methods for treating viral infections
US8222299B2 (en) * 2003-05-23 2012-07-17 Allium Vitalis Incorporated Organosulfur prodrugs for the prevention and treatment of infectious diseases
US20080025986A1 (en) 2003-06-06 2008-01-31 Ozes Osman N Methods of Treating Tnf-Mediated Disorders
DK1670433T3 (da) 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
OA13315A (en) 2003-10-14 2007-04-13 Intermune Inc Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication.
US7491794B2 (en) 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
WO2005040758A2 (en) 2003-10-24 2005-05-06 Intermune, Inc. Use of pirfenidone in therapeutic regimens
US20070258946A1 (en) 2003-12-23 2007-11-08 Blatt Lawrence M Combination Therapy for Treating Hepatitis C Virus Infection
CN100542532C (zh) 2004-05-24 2009-09-23 上海睿星基因技术有限公司 吡非尼酮在制备治疗肝损伤坏死和急性肺损伤的药物中的用途
US20060051339A1 (en) * 2004-09-08 2006-03-09 Sivak Hannah N Composition for treatment of oily skin and acne prevention and methods of making and using same
US20060115503A1 (en) * 2004-11-30 2006-06-01 Goyal Muna C Composition, system and method for treatment of skin
MX2007014114A (es) 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
US20090148407A1 (en) 2005-07-25 2009-06-11 Intermune, Inc. Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
WO2007062167A2 (en) 2005-11-23 2007-05-31 Intermune, Inc. Method of modulating stress-activated protein kinase system
US8586078B2 (en) 2005-12-05 2013-11-19 Rba Pharma Inc. Emulsion-containing medical articles
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
JP2010518125A (ja) 2007-02-12 2010-05-27 インターミューン・インコーポレーテッド Ｃ型肝炎ウイルス複製の新規な阻害剤
CA2679700A1 (en) * 2007-03-02 2008-09-12 Talia Miron Mercaptopurine derivatives as anticancer agents
US20080287508A1 (en) 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
DK2170828T3 (da) 2007-06-20 2013-03-04 Auspex Pharmaceuticals Inc Substituerede n-aryl pyridinoner som fibrotiske inhibitorer
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
US20090137354A1 (en) 2007-11-27 2009-05-28 Shimano Inc. Bicycle rear derailleur
AU2008335717A1 (en) 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US20100256031A1 (en) 2008-10-10 2010-10-07 Jeffrey Wu Shine control cleanser
US7635707B1 (en) 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
TWI434833B (zh) 2009-06-03 2014-04-21 Intermune Inc 用於合成吡非尼酮（ｐｉｒｆｅｎｉｄｏｎｅ）的改良方法
CN101972236A (zh) 2010-10-13 2011-02-16 北京诚创康韵医药科技有限公司 一种含吡非尼酮的缓释制剂
CN101972225A (zh) 2010-10-13 2011-02-16 北京诚创康韵医药科技有限公司 一种含吡非尼酮的凝胶组合物
US10092552B2 (en) 2011-01-31 2018-10-09 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP2675449B1 (en) 2011-02-15 2019-04-24 Aclaris Therapeutics, Inc. Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
CN102670632A (zh) 2011-03-12 2012-09-19 赵海静 吡非尼酮在抑制皮肤瘢痕形成的医药用途
CN102670600A (zh) 2011-03-12 2012-09-19 赵海静 一种抑制瘢痕和促进创口愈合的医药产品,其制备方法和应用
US9241921B2 (en) * 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
CN102488660A (zh) 2011-12-15 2012-06-13 西安天一秦昆制药有限责任公司 一种含吡非尼酮的缓释微丸
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
WO2013181691A1 (en) 2012-06-04 2013-12-12 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor
TW201402133A (zh) 2012-06-12 2014-01-16 Hoffmann La Roche 組合治療性組成物
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
CA2819967C (en) 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9156896B2 (en) 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
EP2968572A1 (en) 2013-03-15 2016-01-20 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
MX352342B (es) 2013-07-12 2017-11-22 Moleculas Naturales S A De C V Star Un procedimiento para fabricar un complejo mejorado de cloruro de bencetonio-dialil oxido de disulfuro modificado, el complejo obtenido y sus usos.
CN103550242B (zh) 2013-11-22 2015-07-15 四川国康药业有限公司 一种治疗肝纤维化的药物组合物及其制备方法
GB201508419D0 (en) 2015-05-15 2015-07-01 Cambridge Entpr Ltd Detection of T cell exhaustion or lack of T cell costimulation and uses thereof
JPWO2017104725A1 (ja) 2015-12-16 2018-10-04 第一三共株式会社 創傷治療剤
JOP20170113B1 (ar) 2016-05-09 2023-03-28 Bayer Pharma AG مركبات 5، 6، 7، 8-رباعي هيدرو [1، 2، 4] تريازولو [4، 3-أ] بيريدين 3(2h)-ون مستبدلة ومركبات 2، 5، 6، 7-رباعي هيدرو-3h-بيرولو [2، 1-ج] [1، 2، 4] تريازول-3-ون واستخداماتها
MX364040B (es) 2016-11-11 2019-04-11 Cell Therapy And Tech S A De C V Uso farmacéutico de una composición que contiene pirfenidona de liberación prolongada (pfd-lp) para la reversión y tratamiento de la esteatohepatitis humana (nafld/nash).
TWI770157B (zh) 2017-04-10 2022-07-11 德商拜耳廠股份有限公司 經取代之n-芳基乙基-2-胺基喹啉-4-甲醯胺及其用途
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
MX368750B (es) 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
AU2021254765A1 (en) 2020-04-14 2022-12-08 Excalibur Pharmaceuticals, Inc. Pirfenidone for coronavirus treatment

Also Published As

Publication number Publication date
US20180353448A1 (en) 2018-12-13
UY34985A (es) 2014-02-28
CA2882392C (en) 2021-10-12
US10792258B2 (en) 2020-10-06
MX2012009806A (es) 2014-02-24
TW201416071A (zh) 2014-05-01
US20210093593A1 (en) 2021-04-01
WO2014030992A3 (es) 2014-10-23
US20190290606A1 (en) 2019-09-26
US20230165819A1 (en) 2023-06-01
US20150231098A1 (en) 2015-08-20
US12083085B2 (en) 2024-09-10
CA2882392A1 (en) 2014-02-27
WO2014030992A2 (es) 2014-02-27
AR092199A1 (es) 2015-04-08

Similar Documents

Publication Publication Date Title
MX356551B (es) Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
EP2418945A4 (en) Mineral salt-sulfuric acid compositions and methods for their use
MX2014011181A (es) Microemulsiones basadas en ciclodextrina y usos dermatologicos de las mismas.
PH12015501887B1 (en) Novel bacteriophage and antibacterial composition comprising the same
MX353942B (es) Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos.
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MX366773B (es) Composicion topica para lavado para su uso en pacientes con acne.
BR112015008847A2 (pt) composições compreendendo ácido peróxido
PH12015501045A1 (en) Bpo wash gel composition
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
PH12012000176A1 (en) Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation
PH12014502154A1 (en) Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne
MY190687A (en) Antimicrobial compositions and related methods of use
BR112012032877A2 (pt) uso de ácido chicórico e derivados para regulagem de pigmentação da pele
MX2018005028A (es) Composicion para el cuidado de la piel y metodos para la misma.
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
CO6680629A2 (es) Compuestos con actividad antibacteriana contra clsotridium
BR112015000186A2 (pt) utilização de coceth sulfato de zinco como agente antibacteriano face o propionibacterium acnes
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
NZ705592A (en) Quick-penetrating soft skin-care cream
BR112014017448A8 (pt) composição dermocosmética contendo como princípio ativo, uma combinação sinérgica de prata coloidal e ácido desoxirribonucleico
BR112015014739A2 (pt) carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
MX2015016799A (es) Composiciones que comprenden un alcohol aromatico y un antagonista de trpv-1, y usos de estos.
PH12015501237A1 (en) Oral care composition

Legal Events

Date Code Title Description
FG Grant or registration